Latest news
Loading news…
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.
PathoQuest on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
PathoQuest was acquired by Charles River Laboratories International in 2026 for $51.6M.
Total Funding
$38.67M
Funding Rounds
5
Last Funding
Acquisitions
0
Monthly Visits
Contacts
21
About PathoQuest
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Paris, Ile-de-France, France
PathoQuest Funding Rounds
5 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 5Show
Page 1 / 1
PathoQuest Key People
Chief Portfolio Officer and General Manager, US Operations
President and CEO
21
professional contacts at PathoQuest
Contact execs at PathoQuest →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about PathoQuest
People who checked this page also checked these
Browse the full Acquirezy directory.